Animal Parasiticides Market Size - Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

Animal parasiticides are veterinary drugs formulated to control external parasites such as fleas, ticks, and mites, as well as internal parasites including roundworms, hookworms, and tapeworms across livestock, poultry, and companion animals. The global market is currently estimated at around USD 10.5 billion in 2025, making it one of the larger and more mature segments within animal health. Consensus forecasts point to a compound annual growth rate of roughly 6.0% through the late 2020s into the early 2030s.

• •Global market size approximately USD 10.5 billion in 2025.
• •Forecast CAGR of about 6.0% through 2030.
• •Long-range projections range from USD 14 billion to USD 20 billion depending on the forecast horizon.

Rising companion animal ownership and willingness to spend on preventive veterinary care are increasing demand for flea, tick, and heartworm products, particularly in North America and Europe. At the same time, expanding global demand for meat and dairy is pushing intensive livestock systems to invest more in parasite control to protect yield and meet food safety standards. Growing awareness of zoonotic diseases such as Lyme disease and echinococcosis is reinforcing the public-health case for routine parasiticides use.

• •Higher pet ownership and per-animal health expenditure in developed markets.
• •Intensification of livestock production in emerging economies.
• •Increased regulatory and public focus on zoonotic disease prevention.

By product, ectoparasiticides and endectocides typically account for the largest revenue share, with endoparasiticides representing a substantial secondary segment; companion animals usually lead on value while livestock leads on volume. By region, North America holds the leading share due to high pet healthcare spending, while Europe is a mature, stable market and Asia-Pacific is the fastest-growing region as pet adoption and commercial livestock production rise. Latin America also contributes meaningful volume, particularly in cattle and poultry parasiticides.

• •Companion animals lead revenue; livestock leads volume.
• •North America is the largest regional market; Asia-Pacific is the fastest growing.
• •Ectoparasiticides and endectocides dominate product mix.

What are the recent trends and outlook?

Innovation is shifting toward longer-acting oral and injectable parasiticides that extend protection periods and improve compliance over traditional monthly topicals. Resistance management in livestock parasites and growing regulatory scrutiny of certain chemical classes are shaping the next generation of active ingredients. Looking ahead, the market is expected to benefit from continued premiumization of pet care, expansion in emerging markets, and integration of parasiticides into broader preventive health and One Health frameworks.

• •Move toward longer-duration oral and injectable formulations.
• •Rising focus on antiparasitic resistance and sustainable chemistry.
• •Stronger integration of parasite control with One Health and zoonotic disease strategies.